Celladon Garners $43,000,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7ac7e5d2-59bf-4caf-9cb9-4cac4bc9c2d9&Preview=1 -
Date
2/16/2012 -
Company Name
Celladon -
Mailing Address
2223 Avenida de la Playa La Jolla, CA 92037 -
Company Description
Celladon Corporation is an exciting new biotechnology company focused on developing treatments for cardiovascular diseases through the application of scientific discoveries in molecular cardiology. -
Website
http://www.celladon.net -
Transaction Type
Venture Equity -
Transaction Amount
$43,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The financing will be used to advance its lead investigational product candidate for the treatment of heart failure. -
M&A Terms
-
Venture Investor
Pfizer Venture Investments -
Venture Investor
Novartis Venture Fund -
Venture Investor
Hambrecht & Quist Capital Management -
Venture Investor
GBS Venture Partners -
Venture Investor
Enterprise Partners Venture Capital -
Venture Investor
Johnson & Johnson Development Corporation -
Venture Investor
Venrock
